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Captopril inhibits the agonist-induced increase of cytosolic free
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Captopril inhibits the agonist-induced increase of cytosolic free Ca2 in
glomerular mesangial cells. To evaluate the underlying mechanism of the
putative renal protective effects of angiotensin converting enzyme (ACE)
inhibitors, the modulatory action of captopril on the angiotensin II (Ang
II) and platelet-derived growth factor (PDGF)-induced increase of cyto-
solic free calcium concentration ([Ca2t]1) was investigated in cultured
glomerular mesangial cells (MC) from spontaneously hypertensive rats
from the MUnster strain (SHR) and normotensive Wistar-Kyoto rats
(WKY). Resting [Ca2]1 was not affected by captopril in MC from either
SHR or WKY. Captopril inhibited the Ang It-induced [Ca2fl increase in
MC from both SHR and WKY in a dose-dependent and time-dependent
fashion. The preincubation of MC with 1 tmol/liter captopril for 40
minutes significantly reduced the Mg It-induced [Ca2]1 increase in SHR
from 167 30 nmol/liter (N = 17) to 74 20 nmol/liter (N = 8,P < 0.05)
and in WKY from 102 42nmol/liter (N = 14) to 43 12 nmol/liter (N
7, P < 0.05). After removal of external calcium there was no significant
effect of captopril on the Mg It-induced [Ca2'j1 increase. With the Mn2
quenching technique, it was confirmed that captopril affects Ca2 influx.
Phospholipase C activity as estimated by diacylglycerol formation was not
changed by captopril. The preincubation of MC with 1 xmoliliter captopril
for 40 minutes significantly reduced the PDGF-induced [Ca2]1 increase in
SHR from 166 54 nmol/liter (N = 9) to 31 19 nmol/liter (N = 6, P <
0.01) and in WKY from 127 31 nmol/litcr (N = 11) toôl 32 nmollliter(N = 5, P < 0.05). Similarly, captopril reduced the [Ca2]1 increase
induced by endothelin and vasopressin. The results indicate that the
actions of Ang II and PDGF on MC are modulated by captopril, probably
resulting in the impairment of the calcium dependent contractile response
of mesangial cells.
Hypertension is commonly associated with advanced renal
insufficiency from any cause [1, 2]. It is well established that
antihypertensive treatment can slow the progression of renal
failure in patients with hypertension and with diabetes mellitus
[3—6]. After the introduction of angiotensin converting enzyme
(ACE) inhibitors evidence accumulated that these drugs may
provide a renal protective effect in addition to their systemic
antihypertensive action [7, 8]. This favorable effect may be
explained taking into account the intrarenal effects of angiotensin
II (Ang II) [9]. The intrarenal effects of Ang II include an increase
of the efferent arteriolar tone, the contraction of mesangial cells
(MC), and the promotion of hypertrophy or hyperplasia of MC
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[10—14]. Assuming that inhibition of the conversion of angiotensin
Ito Ang II is the principal mechanism of action of ACE inhibitors,
their renal protective effects may be accounted for by lowering the
local Ang II concentration.
Recently, another potentially relevant action of ACE inhibitors
has been demonstrated. ACE inhibitors blunted the calcium influx
into vascular smooth muscle cells induced by various agonists
including Ang II [15]. In mesangial cell proliferation and in
glomerulosclerosis several agonists may play a role in inducing a
response in [Ca2]1 in MC, such as platelet-derived growth factor
(PDGF) and Ang II. Accordingly, the renal protective effect of
ACE inhibitors may be mediated by the modulation of Ang II
actions on MC. The present study examined whether captopril can
block the Ang Il-induced increase of [Ca2}1 in MC. The effects of
captopril on the Ang Il-induced [Ca2]1 increase were compared
in MC from spontaneously hypertensive rats from the Münster
strain (SHR) and normotensive Wistar-Kyoto rats (WKY). Fur-
ther, the effects of captopril on the PDGF-induced [Ca2]
increase were measured.
Methods
Animals and culture of glomerular mesangial cells
Three-month-old male spontaneously hypertensive rats from
the Munster strain (SHR) [16] and three-month-old normotensive
Wistar-Kyoto rats (WKY) were fed a standard pellet diet and
water ad libitum. Blood pressure measurements were performed
using a tail cuff. Systolic blood pressure was 195 6 mm Hg
(mean 5EM) for SHR and 116 4 mm Hg for WKY, respec-
tively.
According to previously described methods [12, 13, 17, 18]
whole glomeruli were isolated by serial sieving of minced renal
cortical tissue from blood free rat kidneys. Intact glomeruli
without tubular contamination were digested in collagenase (type
CLS4, 184 U/mI) under continuous gentle shaking at 37°C for 30
minutes according to a modified technique by Striker and Striker
[18]. This procedure results in digestion of the glomerular base-
ment membrane and in shedding of epithelial cells [12]. After
repeated centrifugation and washing, primary cultures of glomer-
ular mesangial cells (MC) were obtained from outgrowths of
remnant glomeruli incubated in MC culture medium supple-
mented with 15% (vol/vol) fetal calf serum (Boehringer Mann-
heim, Germany) at 37°C in a humidified atmosphere of 5%
CO2/95% air. The MC culture medium consisted of RPMI 1640
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medium (Biochrom, Berlin, Germany), (supplemented with 50
U/mi penicillin, 50 tg/ml streptomycin, 1 mmollliter L-glutamine
(Gibco, Eggenstein, Germany), 1 mI/di non-essential amino acids,
and heat-inactivated (56°C, 30 mm) fetal calf serum as indicated.
Until the third passage the MC culture medium also contained 5
g'ml bovine insulin, 5 mgfml transferrin, and 5 ng/ml sodium
selenit [19]. The medium was changed initially after 24 hours and
then every two to three days. Homogenous MC outgrowths were
observed after five to seven days and reached confluency within
two to three weeks. Pure MC cultures were identified by stellate
shaped cells growing in interwoven layers by morphological
characterization and positive immunofluorescent staining for my-
osin, MHC I antigens and extracellular type IV collagen and
fibronectin. Staining for myosin was performed with indirect
immunofluorescence microscopy using rabbit immunoglobulin
(IgG) directed to smooth muscle cell-specific myosin and fluores-
cein isothiocyanate-conjugated goat IgG to rabbit IgG. These
studies showed uniformly strong positive staining of distinct
longitudinal fibrils in all observed cells, which is a staining pattern
considered to be indicative for MC [17]. MC did not stain for rat
common leukocyte antigen, cytokeratin and factor VIII associated
antigen, thus excluding the presence of epitheliai cells or endo-
thelial cells [18, 20]. Confluent monolayers were passaged by
washing MC with physiological salt solution [PSS, containing (in
mmol/liter) NaCI 135, KCI 5, CaCI2 1, MgCl2 1, glucose 5.5, and
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)
10, pH 7.4] with the addition of trypsin (0.125% wt!vol) and
ethylene diamine tetraacetic acic (0.01% wt/vol) for five minutes
at 37°C under gentle agitation before MC culture medium con-
taining 10% fetal calf serum was filled up. The concentration of
fetal calf serum was reduced to 10% after the second passage and
experiments were carried out using MC between the fourth and
sixth passage. Cells were free of mycoplasma as determined by
repeated staining with 4'6'-diamidine-2'-phenylindole dihydro-
chloride (Boehringer Mannheim). Prior to each experiment, the
medium was changed from 10% to 0.5% fetal calf serum for four
days to induce cellular quiescence, leaving the MC in a resting
state, the G'G1 phase [21].
Measurements of cytosolic free calcium concentration ([Ca2])
[Ca2] in MC was measured using the calcium-sensitive fluo-
rescent dye fura2 according to previously described methods [19,
22, 23]. A stock solution of the cell-permeant fura2-acetoxym-
ethyester (fura2-AM) was prepared in dimethylsulfoxide at a final
concentration of 1 mmollliter. MC grown on 13 mm round glass
coversiips were washed with warm PSS (containing 0.1% bovine
serum albumin, pH 7.4) and incubated with 5 mol/liter
fura2-AM and 0.02% (wt/vol) non-ionic surfactant Pluronic F-127
(Molecular Probes, Eugene, Oregon, USA) for 60 minutes at
37°C. At the end of the loading period MC on coverslips were
washed twice with PSS without bovine serum albumin, and
experiments were continued only when a cell viability higher than
95% was observed by Trypan blue exclusion. MC on coverslips
were inserted into 10 x 10 mm quartz glass cuvettes and placed in
the thermostated holder of a Spectrofluorophotometer RF-5001
PC (Shimadzu, Tokyo, Japan) with intracellular calcium measure-
ment software (Shimadzu). Light source was a 150 W xenon lamp
with ozone self-dissociation function. The wavelength drive mo-
tors and slit control motors were operated by the computer. The
wavelength accuracy was better than nm. Output signals from
the monitor detector and fluorescence detector (photomuitiplier)
were processed via the A/D converter. Data sampling interval was
1 second with alternate excitation wavelengths of 340 nm and 380
nm (band width 5 nm), and emission was collected at 510 nm
(band width 5 nm). The complete hydrolysis of fura2-AM to fura2
was judged by changes in the excitation and emission spectra.
Fluorescence values were corrected for cellular autofluorescence.
The autofluorescence of MC was about 50 times lower than the
fluorescence of MC loaded with fura2. To minimize temperature-
dependent dye leakage from the MC measurements were under-
taken at 24°C. The ratio (R) of the measured fluorescence values
at 340 nm and 380 nm excitation was calculated. As reported by
Cobbold and Rink [24] for fura2, which exists in only two forms,
free and calcium-bound, the signal from these two wavelength
pairs is uniquely determined by the ratio of free and bound dye
and therefore by [Ca2]1. The F3401F380 nm excitation ratio in
resting MC remained constant during the measurement period,
indicating a stable [Ca2]1. At the end of each measurement
1 mmol/liter digitonin, then 5 mmol/liter ethyleneglycol-bis-(ammno-
ethylether)-tetraacetic acid (EGTA) were sequentially added to
determine the maximum (Rmax) and the minimum (Rmin) of the
F340nm/F380 nm excitation fluorescence ratio. Control experi-
ments confirmed that further increase of digitonin or EGTA
concentration had no effect on Rm or Rmin, respectively. [Ca2]1
was calculated according to the equation reported by Giyn-
kiewicz, Poenie and Tsien [25] [Ca2]1 = K * (RRmjn)/(RmR).
K is Kd * Fmin/Fm, the latter representing the ratio of the
fluorescence at 380 nm excitation measured in EGTA plus
digitonin to that measured in 1 mmol/liter external Ca2 plus
digitonin, and Kd represents the dissociation constant of fura2 for
Ca2t which was reported to be 224 nmollliter [25]. Using this
method (internal calibration method), absolute [Ca2]1 is calcu-
lated even in the presence of background fluorescence [26, 27].
Cytosolic fura2 concentration was estimated to be less than 100
pmol/liter by comparing the fluorescence of a standard solution of
fura2 free acid in the presence of unloaded cells. That fura2
concentration allows this contribution to be minimized to the total
calcium-buffering system [28]. To stimulate MC 100 nmol/liter
angiotensin II, 10 ng/ml PDGF, 100 nmollliter vasopressmn or 100
nmol/liter endothelin were used. The autofluorescence of these
agonists was negligible.
Ca2 influx measurements using Mn Cl2
The entry of manganese into MC was measured using the fura2
quenching technique [29]. MC were loaded as for [Ca2] mea-
surements and fura2 fluorescence monitored in a calcium-con-
taining medium at the Ca2-insensitive excitation wavelength 360
nm. Then, 0.5 mmollliter manganese was added, and its entry into
MC was measured as the rate of fluorescence decrease.
Measurements of phospholipase C activity
Measurements of inositol phospholipid breakdown products
were undertaken as previously reported by Kester et al [30].
Confluent cultures in 35 mm dishes were labeled with 0.5 Ci/ml
[14C]-arachidonic acid (Amersham, Braunschweig, Germany)
over a 12 hour incubation. Preliminary experiments demonstrated
that steady state incorporation of tracer had occurred by the end
of the labeling period. Cell monolayers were rinsed with PSS and
incubated with 1 mol/liter captopril or buffer for control for 40
minutes at 37°C and stimulated with 100 nmolll Ang II. The
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incubation was stopped by quickly aspirating the medium and
adding 1 ml of ice-cold 0.2 mol/liter NaOH. Cells were scraped
with a rubber policeman, and the dishes rinsed with 1 ml of 0.2
mol/liter NaOH. Radioactive lipids were extracted by the method
of Bligh and Dyer [31] and 1,2 diacylglycerol was separated by thin
layer chromatography on silica gel 60 plates (Merck, Darmstadt,
Germany) with the solvent system of toluol/ether/ethanol/tri-
ethylamine (100:80:4:2, vol/vol/vol/vol) as described previously
[32]. The individual lipids, identified by co-migration with com-
mercial standards (Sigma), were visualized in iodine vapor, and
radioactivity was determined in the silica gel scrapings by liquid
scintillation counting in a 1214 scintillation counter (LKB,
Bromma, Sweden).
All substances were purchased from Sigma (Deisenhofen,
Germany) if not indicated otherwise. Captopril was purchased
from Sigma. Enalaprilat was provided by MSD Sharp & Dohme
(Munich, Germany). Stock solutions of captopril and enalaprilat
were made in bidistilled water. Solutions of the desired concen-
trations were made in physiological salt solution. Time paired
control experiments showed no effect of buffer alone. Angiotensin
II was obtained in a highly purified grade for tissue cultures from
Sigma. Antisera for immunohistochemistry were purchased from
ICN (Eschwege, Germany), Sigma, or Boehringer Mannheim.
Recombinant platelet-derived growth factor (PDGF A/B) was
expressed by E. coli and highly purified by standard chromato-
graphic techniques (Boehringer Mannheim).
Statistics
All data are presented as mean standard error. For statistical
evaluation of the data Wilcoxon's test was used. Two-tailed P
values less than 0.05 were considered to be significant. Original
tracings shown in the figures are representative for at least five
separate experiments.
Results
Effect of captopril on resting [Ca2] in MC
As shown in Figure 1, the [Ca2}1 in resting MC was not
significantly different between SHR and WKY (48 5 nmol/liter,
N = 42 vs. 44 5 nmol/liter, N 38). After preincubation with
1 mol/liter captopril for 40 minutes the resting [Ca2] was not
significantly changed in MC from SHR (58 9 nmol/liter, N
15) or WKY (52 9 nmol/liter, N = 18).
Effect of captopril on Ang 11-induced [Ca2], increase
Stimulation of MC by 100 nmollliter Ang II increased [Ca2]1 in
MC. The Ang Il-induced [Ca2] increase was significantly higher
in MC from SHR compared to WKY (167 30 nmol/liter, N =
17, vs. 102 42 nmol/liter, N = 14, P < 0.05). Preincubation of
MC from both WKY and SHR with 1 j.mol/liter captopril for 40
minutes significantly reduced the Ang Il-induced [Ca2], increase
in glomerular mesangial cells. The data are summarized in Table
1 and Figures 2 and 3.
Effect of captopril on PDGF, vasopressin, and endothelin induced
[Ca2]1 increase
Next the question arises whether the inhibitory effect of capto-
pril on Ang Il-induced [Ca2]1 increase in MC was agonist
specific. Therefore, MC were stimulated with PDGF. The [Ca2]1
increase induced by 10 ng/ml PDGF was not significantly different
Fig. 1. Resting cytosolic-free calcium concentration ([Ca2],) in glomerular
mesangial cells (MC) from spontaneously hypertensive rats of the Münster
strain (N) and normotensive Wistar-Kyoto rats (El). [Ca2 I was measured
spectrofluorophotmetrically in cultured MC grown on cover slips using the
fluorescent dye fura2. Resting [Ca21] was measured under control
conditions (Control) and 40 minutes after the administration of 1 mol/
liter captopril. Mean values SEM are shown.
SHR N WKY N
Control 167 30 17 102 42 14
Captopril 74 20b 8 43 12b 7
Fura2 loaded MC from spontaneously hypertensive rats from the
Munster strain (SHR) or normotensive Wistar-Kyoto rats (WKY) were
incubated with buffer for control or with 1 molJliter captopril for 40
minutes prior to the addition of 100 nmol/liter Aug II. Data represent the
Ang TI-induced [Ca2]1 increase minus respective baseline value. Data are
mean SEM from N experiments.
ap < 0.05 between SHR control and WKY control value
'P < 0,05 compared to the respective control value
in MC from SHR and WKY (166 54 nmol/liter, N =9, vs. 127
31 nmol/liter, N 11, Fig. 4). After preincubation with 1
molIliter captopril for 40 minutes the PDGF-induced [Ca2]1
increase was significantly reduced in MC of SHR from 166 54
nmol/liter (N 9) to 31 19 nmol/liter (N = 6, P < 0.01) and in
MC of WKY from 127 31 nmol/liter (N 11) to 61 31
nmol/liter (N = 5, P = 0.05, Fig. 4).
The [Ca2] increase induced by 100 nmol/liter vasopressin was
significantly reduced after preincubation with captopril for 40
minutes in SHR from 252 55 nmol/liter (N = 4) to 140 24
nmol/liter (N = 5) and in WKY from 209 31 nmol/liter (N =8)
to 131 15 nmol/liter (N 7, P < 0.05). Likewise, preincubation
with captopril reduced the [Ca2] increase induced by 100
nmol/liter endothelin in SHR from 210 10 nmol/liter (N 4) to
115 22 (N = 3) and in WKY from 199 8 nmol/liter (N = 4)
to 125 18 (N = 4, P < 0.05).
75
E
+
C-)
50
25
Control Captopril
Table 1. Effect of captopril on the angiotensin II (LAng 11) induced
increase of cytosolic-free calcium concentration ([Ca f]) in glomerular
mesangial cells
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Fig. 3. Effect of captopril on angiotensin II (Ang II) -induced changes of
cytosolic free calcium concentration (i[Ca2]1) in glomerular mesangial cells
(MC). Fura2 loaded MC from spontaneously hypertensive rats from the
Münster strain (SHR, •) or normotensive Wistar-Kyoto rats (WKY, 0)
were incubated with buffer for control or with 1 smol/liter captopril for 40
minutes prior to the addition of 100 nmollliter Ang II. Data represent the
Ang LI-induced [Ca2] increase minus respective baseline value. Data are
mean SEM. * P < 0.05 between SHR control and WKY control value;
+ P < 0.05 compared to the appropriate control value.
0
Fig. 2. Effect of captopril on increase in
cytosolic-free calcium concentration ([Ca2J)
induced by angiotensin II (Ang II) in glomerular
mesangial cells (MC). MC were incubated with
buffer alone for control (A) or with 1 smol/liter
captopril (B) for 40 minutes. Then 100 nmol/
liter Ang II were added at the indicated time.
Upper panel, fluorescence signal at 340 nm
(upper curve) and 380 nm excitation (lower
curve). Lower panel, [Ca2]1. Tracings are
representative for 17 (A) and 8 (B) similar
experiments.
Fig. 4. Effect of captopril on platelet-denved growth factor (PDGF)-induced
changes of cytosolic free calcium concentration (t[Ca2]1) in glomerular
mesangial cells (MC). Fura2 loaded MC from spontaneously hypertensive
rats from the MUnster strain (•) or normotensive Wistar-Kyoto rats (0)
were incubated with buffer for control or with 1 mol/liter captopril for 40
minutes prior to the addition of 10 nglml PDGF. Data represent mean
values of the PDGF-induced [Ca2]1 increase minus respective baseline
value. Data are mean SaM. ÷ P < 0.05 compared to the appropriate
control value.
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Time dependent effect of captopril
Next we evaluated whether the effect of captopril on the Ang
Il-induced [Ca2]1 increase in MC from SHR was dependent on
the preincubation time. As shown in Figure 5, the maximum
inhibition of the Ang II response was achieved after a 30 minute
incubation with 1 j.tmollliter captopril in both strains.
Concentration dependence of captopril effects
Figure 6 shows a concentration-response curve of the effect of
captopril on the Mg H response in MC. The inhibitory effect was
observed with captopril concentrations of i07 mol/liter and was
maximal with iO mol/liter.
Influence of external calcium on captopril effects
After removal of external calcium by addition of 5 mmol/liter
EGTA 30 seconds prior to the administration of Mg II, there was
no significant effect of captopril on the Mg TI-induced [Ca2],
increase in MC (10 1 nmol/liter, N = 6, vs. 10 2 nmollliter,
N = 6). In the absence of extracellular calcium the vasopressin
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Fig. 5. Time dependent effect of captopril on angiotensin II (Ang 11)-induced
changes of cytosolic-free calcium concentration (L[Ca2]) in glomerular
mesangial cells (Mc). MC from spontaneously hypertensive rats from the
Münster strain (•) or normotensive Wistar-Kyoto rats (0) were incu-
bated with 1 smol/Iiter captopril for 10 to 40 minutes prior to the
administration of 100 ng/ml Ang H. At 0 minutes the Ang Il-induced
[Ca2]1 increase in the absence of captopril is shown, Data represent mean
values of the Ang Il-induced [Ca2] increase minus respective baseline
value. Data are mean SuM.
Fig. 7. Effect of captopril on angiotensin Il-induced Mn2 ently into
mesangial cells (MC) as measured by fura2 quenching. Fura 2 loaded MC
were incubated with buffer alone for control or with 1 tmol/liter captopril
for 40 minutes. Then 100 nmol/liter angiotensin II (Ang H) were added at
the indicated time. Fluorescence was measured at the Ca2-insensitive
excitation wavelength of 360 nm. Tracings are representative for five
similar experiments.
log [captopril], mo//liter
Fig. 6. Concentration-dependent effect of captopril on angiotensin II (Ang
11)-induced changes of cytosolic-free calcium concentration (L[Ca2]) in
glomerular mesangial cells (MC). MC from spontaneously hypertensive rats
from the MUnster strain (SHR) were incubated with increasing captopril
concentrations as indicated for 40 minutes prior to the administration of
100 ng/nTil Mg H. Data represent mean values of the Mg TI-induced
[Ca2]1 increase minus respective baseline value. Data are mean SEM.
Ctrl denotes the control administration of 100 nmo/liter Ang H in the
absence of captopril.
induced [Ca2], increase was 108 18 nmol/liter (N 5) and 104
9 nmol/liter (N = 5) with and without captopril incubation,
respectively. These results indicate that the effect of captopril was
due to inhibition of agonist induced transpiasma membrane
calcium influx.
Effect ofcaptopril on Ca2 inflw
The effect of captopril on the Ang II induced transpiasma
membrane calcium influx was investigated using the manganese
quenching technique. After stimulation of MC by Ang lithe fura2
fluorescence at the Ca2 independent excitation wavelength 360
nm decreased due to manganese influx. After preincubation of
MC with captopril, the Mg Il-induced decrease of the fura2
fluorescence, such as the transplasma membrane manganese
influx, was markedly diminished (Fig. 7).
Effect of verapamil on Ang Il-induced [Ca2]1 increase
Lack of effect of captopril on phospholipase C activity
In rat mesangial cells Ang II activates phosphoinositide-specific
phospholipase C, resulting in the generation of 1,2 diacyiglycerol
in ['4C]-arachidonic acid labeled cells. Addition of 100 nrnol/liter
Ang II resulted in a rapid increase in [14C]DAG, which peaked at
30 to 60 seconds to 153 + 11% of control values (N = 2). No
significant difference in [14C}-DAG generation was observed after
preincubation with 1 .rmollliter captopril for 40 minutes (peak 148
9% of control).
Effect of enalaprilat on Ang I1'-induced [Ca2], increase
Incubation with 1 jrmol/liter enalaprilat for 40 minutes signifi-
cantly reduced the Mg TI-induced [Ca2]1 increase in MC from
167 30 nmol/liter (N 17) to 64 34 nmol/liter (N = 6;
P < 0.05).
I..
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'I
200
100
0
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Time, minutes
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200
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To compare the effects of captopril on the Ang II induced
calcium influx with that of a calcium channel blocker, the effects
— ofverapamil on the Mg II induced [Ca2]. increase were studied.
When 10 j.molIliter verapamil were added to mesangial cells 50
seconds prior to the addition of 100 nmol/liter Ang II, the [Ca2}
increase was significantly reduced from 131 8 nmollliter (N =4)
to 84 4 nmol/liter (N = 6, P < 0.05).
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Discussion
The present study was undertaken to clarify whether captopril
modulates the effects of Ang II on MC from spontaneously
hypertensive and normotensive rats. Therefore, [Ca2]1 was mea-
sured in cultured MC from SHR and WKY using the fluorescent
dye technique. Resting [Ca2]1 in MC was not significantly
different between both strains whereas the Ang Il-induced [Ca2]
increase was significantly higher in MC from SHR compared to
WKY. These findings are in agreement with those by Osanai and
Dunn, who also showed a similar resting [Ca2] in MC from SHR
and WKY and an increased Ang II response in hypertensive MC
[19]. Contraction of MC reduces glomerular filtration surface area
and hence the ultrafiltration coefficient [33], thereby possibly
enhancing sodium and volume retention. Therefore, the increased
response of MC from SHR to Ang II may contribute to the
pathophysiology of primary hypertension. It is of interest that the
hyperresponsiveness of [Ca2]1 increase in MC was agonist spe-
cific, since the [Ca2]1 increase induced by PDGF was not
significantly different between the two strains.
The results show that the Ang IT-induced [Ca2] increase is
inhibited by captopril in MC from both SHR and WKY. The
effects of captopril on Ang IT-induced calcium [Ca2]1 increase
are similar to those recently observed in vascular smooth muscle
cells [15]. Captopril affected only the Ang Il-induced calcium
influx, as the modulatory effect of captopril on the Ang Il-induced
[Ca2] increase in MC was abolished in the absence of external
calcium. Enalaprilat was similarly effective as captopril. Since the
inhibition of Ang Il-induced calcium influx was observed with
captopril concentrations as low as iO mol/liter, this effect may
also occur with therapeutic concentrations, which are in the range
of 5 to 10 .tmolIliter captopril [34]. It should be noted that
preincubation with captopril did not change the resting [Ca2]1 in
MC.
Although the experiments suggest a direct effect of ACE
inhibitors on agonist-induced [Ca2] increase, it cannot be ex-
cluded that ACE inhibition may somehow be involved in the
observed actions, since in MC both ACE and angiotensinogen was
found [35]. However, at present it cannot be explained how ACE
inhibition in MC cells can modify the response to exogenous Ang
II. To postulate a link between the observed captopril effects and
its ACE inhibitory action, a role of ACE in MC in signal
transduction has to be assumed.
Experiments using the fura2-quenching technique confirmed
that captopril primarily acts on agonist-induced transplasma
membrane calcium influx. The mechanisms by which ACE inhib-
itors decrease the agonist-induced Ca2 influx remain unknown.
It may be speculated that signal transduction by activation of
phospholipase C could be affected. However, the generation of 1,2
DAG was not affected by captopril. Therefore, captopril may not
affect the stimulatory action of Ang II on the phospholipase C,
provided that there is no simultaneous change in phospholipase D
activity, since the latter enzyme can also contribute to DAG
production.
The slow onset of action raises the suspicion that captopril acts
on calcium influx after diffusion into the cells or after induction of
secondary processes. Since Ca2 channel blockers such as vera-
pamil show an immediate action on Ca2 channels, the findings
suggest that the effect of captopril cannot simply be explained as
a Ca2 channel blockade. In vascular smooth muscle cells,
captopril was recently shown not to inhibit the Ca2 influx
induced by BayK 8644, supporting the concept that the site of
action is not the Ca2 channel, but the postreceptor signal
transduction [15].
The clinical relevance of this action of captopril relative to the
well-established inhibition of the angiotensin converting enzyme
is difficult to assess. The inhibition of the response to both Ang II
and PDGF may contribute to the beneficial effects of ACE
inhibitors on renal function.
The response of MC to PDGF is inhibited by captopril like the
Ang II response. PDGF has been shown to stimulate contraction
and an increase in [Ca2]1 [23, 36], mitogenic activity [37] and
extracellular matrix deposition in MC [38, 39]. PDGF-induced
proliferation may play a role in several disorders, such as exper-
imental glomerulonephritis [40, 41], increased glomerular cell
proliferation after 5/6 nephrectomy [42], and in diabetic nephrop-
athy [43]. By antibodies to PDGF, MC proliferation and matrix
expansion in experimental glomerulonephritis can be prevented
[44]. Therefore, the inhibition of the PDGF-induced [Ca2]1
increase by captopril may contribute to its renal protective effect.
In summary, the present results point to an additional mecha-
nism of the action of ACE inhibitors on MC. The modulatory
effect of captopril on the Ang II and PDGF-induced [Ca2]1
increase in MC may be related to the renal protective effects of
these drugs.
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